Cannes Favorite Anora: A Deep Dive Into Its Talented Cast
The indie film Anora has quickly captured the attention of audiences and critics alike, especially after its strong showing at international film festivals in 2024 and 2025. As buzz continues to build around this unique drama-comedy, viewers are eager to learn more about the
In this blog post, we’ll explore the cast of Anora, highlight the breakout performances, and provide key background on the stars and what to expect next.
What Is Anora About?
Before diving into the cast, let’s quickly recap what Anora is all about. Directed by Sean Baker — known for his raw and realistic storytelling in films like
Meet the Anora Cast
Mikey Madison as Anora
The lead role of Anora is played by Mikey Madison, best known for her work in Once Upon a Time in Hollywood
Her portrayal of Anora brings depth to a character that could have easily been one-dimensional. Madison’s chemistry with her co-stars also helps ground the film in authentic emotion.
Mark Eidelstein as Ivan
Playing opposite Madison is Mark Eidelstein, a relative newcomer to Hollywood, but one who leaves a lasting impression. Eidelstein plays Ivan, the wealthy and impulsive son of a Russian oligarch who falls head-over-heels for Anora. His portrayal is layered, mixing innocence, recklessness, and genuine affection, all while navigating the chaos of class differences and cultural expectations.
Despite being newer to the scene, Eidelstein's performance holds its own against Madison’s, and the two share a natural, believable chemistry.
Supporting Anora Cast Members Worth Watching
While the leads are undeniably the stars of the show, the supporting cast also brings crucial texture and realism to the world of
Karren Karagulian
A frequent collaborator of director Sean Baker, Karren Karagulian plays a supporting role that adds both humor and heart to the film. Known for his work in
Vache Tovmasyan
Armenian comedian and actor Vache Tovmasyan also appears in
Why the Anora Cast Stands Out
One of the most impressive aspects of the Anora cast is its diversity and authenticity. Director Sean Baker is known for casting actors who can portray raw, relatable characters, and
The performances are not overly polished — and that’s a good thing. Instead, the cast leans into realism, allowing the characters to be flawed, funny, and fully human.
Festival Buzz and Awards Potential
Anora debuted at the 2024 Cannes Film Festival, where it received a standing ovation and major praise for both direction and acting. The Anora cast
With awards season approaching, many are speculating that Mikey Madison could be in line for a Best Actress nomination, and the film as a whole may get nods for Best Original Screenplay and Best Director.
What’s Next for the Anora Cast?
Following the success of Anora, it’s expected that many of the cast members will see their careers skyrocket.
-
Mikey Madison is already in talks for major studio projects, with her performance in
Anora solidifying her status as one of the most promising young actresses in Hollywood. -
Mark Eidelstein has reportedly signed with a top-tier talent agency and is being considered for several upcoming streaming and theatrical projects.
-
Karren Karagulian continues to build on his reputation as a staple in indie cinema.
Why You Should Keep an Eye on the Anora Cast
The Anora cast is more than just a group of actors — it’s a dynamic team that brought a raw, emotional, and deeply engaging story to life. With powerful performances from Mikey Madison and Mark Eidelstein, and strong support from a culturally rich ensemble,
Whether you’re a fan of award-winning performances, independent cinema, or rising Hollywood stars, the Anora cast
Dad with deadly brain cancer that kills in a year is cancer free after taking new drug
A breakthrough drug is fighting brain cancer head-on.
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year. There is no cure for the highly aggressive disease — many patients survive just nine months after diagnosis.
Ben Trotman was diagnosed with glioblastoma in October 2022 at 40.
Treatment focuses on managing symptoms and extending life via surgery to remove as much of the tumor as possible and radiation therapy and chemotherapy to destroy cancer cells.
Now, researchers from University College London Hospitals are recruiting glioblastoma patients for a trial of the immunotherapy drug ipilimumab. Sold under the brand name Yervoy, the monoclonal antibody stimulates the immune system to recognize and attack cancer cells.
Oncologists are optimistic since a UK father shows no signs of having a tumor after he took ipilimumab before his glioblastoma treatment.
Ben Trotman was diagnosed with glioblastoma in October 2022 at 40.
“The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy,” said Dr. Paul Mulholland, the consultant medical oncologist leading the trial.
“We saw with Ben, the one patient recruited to the immunotherapy study, NeAT-GLIO, that he has had clear scans since having the treatment and the tumor hasn’t returned more than two and a half years later.”
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year.
Trotman met with Mulholland, who enrolled him in a clinical trial for ipilimumab. He was the first patient in the world — and the only person in the trial — to take the drug before glioblastoma treatment.
“Getting this diagnosis was the most traumatic experience,” said Trotman’s wife, Emily.
“We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live.”
After taking the drug, Ben underwent radiotherapy and chemotherapy.
Two years and eight months later, his scans are clear.
“It is very unusual to have a clear scan with glioblastoma, especially when he didn’t have the follow-up surgery that had been planned to remove all of the tumor that was initially visible on scans,” Mulholland said.
Ben and Emily Trotman wed in 2023, after he began his immunotherapy treatment.
“We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumor at bay,” he added, “and it has so far, which we are delighted to see.”
In January 2023, months after his diagnosis, Ben married Emily. The couple welcomed a daughter, Mabel, earlier this year.
They enjoy taking her for walks along with their rescue dog, Jerry.
“We are trying to live as normal a life as possible,” Emily said.
“We are in a unique position of which there is no precedent and which comes with a great deal of uncertainty,” she continued. “We want to live each day as if it were our last, but we also want to plan for the future, which we hope to have.”
Researchers plan to recruit 16 glioblastoma patients like Ben over 18 months.
After taking ipilimumab, the trial participants will undergo radiotherapy and chemotherapy and perhaps surgery depending on the extent of their disease.
Dr. Paul Mulholland and Dame Siobhain McDonagh, who raised funds for the new clinical trial of ipilimumab.
The trial is being funded by Dame Siobhain McDonagh, a member of the British Parliament, whose sister died of glioblastoma in 2023.
“My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma,” McDonagh said. “Changing this was Margaret’s final campaign and one that I have continued in her memory.”
Treatment will take place at the NIHR UCLH’s Clinical Research Facility at the National Hospital for Neurology and Neurosurgery.
“I am delighted that this new trial, with the same immunotherapy drug I received, is going ahead and others will have the opportunity to take part,” Ben said. “It will give people newly diagnosed with glioblastoma some hope.”
